Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timur Liwinski

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Cell Discovery|June 19, 2020
Inflammasome activation and regulation: toward a better understanding of complex mechanismsDanping Zheng, Timur Liwinski, Eran Elinav
The Lancet. Psychiatry|March 9, 2024
A milestone in patient-centred careTimur Liwinski, Christian G Huber, Undine E Lang
Frontiers in Immunology|April 12, 2018
Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic RelevanceMarcial Sebode, Christina Weiler-Normann, Timur Liwinski, et al.
Biomedicines|December 23, 2023
Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain AxisTimur Liwinski, Undine E Lang, Annette B Brühl, et al.
Frontiers in Psychiatry|January 30, 2023
Who is afraid of Christmas? The effect of Christmas and Easter holidays on psychiatric hospitalizations and emergencies-Systematic review and single center experience from 2012 to 2021Else Schneider, Timur Liwinski, Lukas Imfeld, et al.
Frontiers in Psychiatry|February 7, 2024
Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxietyJohannes Hauser, Jan Sarlon, Timur Liwinski, et al.
Journal of Affective Disorders|January 23, 2026
Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational studyJan Sarlon, Deanne Thomi, Annette B Brühl, et al.
Neuroscience Applied|November 14, 2025
Efficacy and safety of intravenously applied caffeine augmentation in electroconvulsive therapyMagdalena D Ridder, Sarah Ulrich, Richard Vettermann, et al.
Neuroscience Applied|December 1, 2025
Electroconvulsive therapy reduces suicidality and all-cause mortality in refractory depression: A systematic review and meta-analysis of neurostimulation studiesJolein Odermatt, Jan Sarlon, Neysan Schaefer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2024
Adjunctive use of mindfulness-based mobile application in depression: randomized controlled studyJan Sarlon, Else Schneider, Annette B Brühl, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Cell Discovery|June 19, 2020
Inflammasome activation and regulation: toward a better understanding of complex mechanismsDanping Zheng, Timur Liwinski, Eran Elinav
The Lancet. Psychiatry|March 9, 2024
A milestone in patient-centred careTimur Liwinski, Christian G Huber, Undine E Lang
Frontiers in Immunology|April 12, 2018
Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic RelevanceMarcial Sebode, Christina Weiler-Normann, Timur Liwinski, et al.
Biomedicines|December 23, 2023
Exploring the Therapeutic Potential of Gamma-Aminobutyric Acid in Stress and Depressive Disorders through the Gut-Brain AxisTimur Liwinski, Undine E Lang, Annette B Brühl, et al.
Frontiers in Psychiatry|January 30, 2023
Who is afraid of Christmas? The effect of Christmas and Easter holidays on psychiatric hospitalizations and emergencies-Systematic review and single center experience from 2012 to 2021Else Schneider, Timur Liwinski, Lukas Imfeld, et al.
Frontiers in Psychiatry|February 7, 2024
Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depression correlates with better tolerability and reduced anxietyJohannes Hauser, Jan Sarlon, Timur Liwinski, et al.
Journal of Affective Disorders|January 23, 2026
Real-world comparison of intranasal racemic ketamine and esketamine in treatment-resistant depression: A retrospective observational studyJan Sarlon, Deanne Thomi, Annette B Brühl, et al.
Neuroscience Applied|November 14, 2025
Efficacy and safety of intravenously applied caffeine augmentation in electroconvulsive therapyMagdalena D Ridder, Sarah Ulrich, Richard Vettermann, et al.
Neuroscience Applied|December 1, 2025
Electroconvulsive therapy reduces suicidality and all-cause mortality in refractory depression: A systematic review and meta-analysis of neurostimulation studiesJolein Odermatt, Jan Sarlon, Neysan Schaefer, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 4, 2024
Adjunctive use of mindfulness-based mobile application in depression: randomized controlled studyJan Sarlon, Else Schneider, Annette B Brühl, et al.
Pageof 5